
[section label=”Episode” bg_color=”rgb(255, 255, 255)” padding=”0px” padding__sm=”0px” padding__md=”0px”]
[row style=”collapse” h_align=”center”]
[col span=”7″ span__sm=”12″ span__md=”10″ margin=”0px 0px 30px 0px”]
[/col]
[col span=”7″ span__sm=”12″ span__md=”10″ padding=”0px 0px 0 0px” margin=”0px 0px 30px 0px” class=”imagecaption”]
[ux_image id=”15894″ image_size=”original” width__sm=”100″]
[/col]
[col span=”7″ span__sm=”12″ span__md=”10″]
[title text=”In today’s episode:” tag_name=”h4″ margin_top=”0px” margin_bottom=”10px” size=”75″ class=”todaysepisode”]
[row_inner class=”podcastbody”]
[col_inner span__sm=”12″]
The law makes heroin, cocaine, and meth illegal according to their defined chemical structures. But what about drugs made from synthetic compounds, which can be changed with a tiny tweak in a clandestine lab? Can the law just say “close enough?”
Jordan Rubin is a legal editor at Bloomberg Law and co-host of the Cases & Controversies podcast.
-
“America’s Secret Drug War,” August 2019
[/col_inner]
[/row_inner]
[divider width=”100%” height=”1px”]
[block id=”11698″]
[/col]
[/row]
[/section]